Medical
Endo Partners with Paladin Pharma to Launch Wynzora® Cream in Canada
Endo, Inc. (OTCQX: NDOI) has recently solidified its presence in the Canadian pharmaceutical market through a definitive agreement with MC2 Therapeutics to commercialize Wynzora® Cream...
ANGLE plc Unveils Innovative PD-L1 Assay for Lung Cancer at AACR Conference
ANGLE plc (OTCQX: ANPCY), a leader in liquid biopsy technology, has made significant strides in cancer diagnostics with the introduction of its PD-L1 assay, showcased...
Vaso Corporation Reports Third Quarter 2024 Financial Performance and Future Outlook
Vaso Corporation (OTCQX: VASO), a prominent player in the medtech industry, has released its financial results for the third quarter of 2024, showcasing a mix...
Orgenesis Advances Accessibility in Cell and Gene Therapies
Orgenesis Inc. (OTCQX: ORGS), a global biotech company has recently shared its business update for the third quarter ending September 30, 2024. The company is...
HPQ Silicon Advances Fumed Silica Reactor Project Towards Commercial Production
HPQ Silicon Inc. (trading (TSX-V: HPQ, OTCQB: HPQFF, FRA: O08) is making significant strides in the development of its proprietary Fumed Silica Reactor (FSR) technology,...
Cresco Labs Reports Strong Financial Performance in Q3 2024: A Testament to Cash Flow Strategy
Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ), a leading name in the branded cannabis market and operator of Sunnyside dispensaries, has announced its...
Emerging Laser Technologies and the Future of Medicine
The landscape of medical treatment is undergoing a significant transformation, largely driven by advancements in laser technology. Lasers, which were once primarily confined to niche...
Gabelli Funds and Columbia Business School Collaborate for 6th Annual Healthcare Symposium
Gabelli Funds, LLC, in collaboration with Columbia Business School, is set to host the 6th Annual Healthcare Symposium on November 15, 2024, at the Paley...
InHouse by MariMed Launches Initiative to Assist Veterans with Housing Challenges
In a significant move to support veterans facing housing difficulties, InHouse™, a brand under MariMed Inc. (CSE: MRMD, OTCQX: MRMD), has announced the launch of...
Orexo AB Launches New Study of OX640 for Treating Allergic Rhinitis
Orexo AB (STO: ORX, OTCQX: ORXOY), a Sweden-based pharmaceutical company, announced today the initiation of a new clinical study for its intranasal medication, OX640, targeting...
